Wager; Travis T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wager; Travis T..The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".
Company Profile
9.25.27
- Wager; Travis T. - Brookline MA
- Wager; Travis T. - New London CT US
- Wager; Travis T - New London CT
Patent Activity
| Patent | Date |
|---|---|
| 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Grant 11,390,623 - Chappie , et al. July 19, 2 | 2022-07-19 |
| Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Grant 11,312,713 - Brodney , et al. April 26, 2 | 2022-04-26 |
| Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors App 20210355117 - BRODNEY; Michael Aaron ; et al. | 2021-11-18 |
| Cyclic substituted imidazo[4,5-c]quinoline derivatives Grant 11,161,844 - Chappie , et al. November 2, 2 | 2021-11-02 |
| 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Grant 10,738,063 - Chappie , et al. A | 2020-08-11 |
| 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine Dopamine D3 Ligands App 20200157098 - Chappie; Thomas Allen ; et al. | 2020-05-21 |
| 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Grant 10,590,128 - Chappie , et al. | 2020-03-17 |
| Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives App 20200039977 - Chappie; Thomas Allen ; et al. | 2020-02-06 |
| 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds App 20190300546 - Chappie; Thomas Allen ; et al. | 2019-10-03 |
| Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors App 20190263816 - Chappie; Thomas Allen ; et al. | 2019-08-29 |
| 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Grant 10,323,042 - Chappie , et al. | 2019-06-18 |
| 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds App 20190055262 - Chappie; Thomas Allen ; et al. | 2019-02-21 |
| 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS App 20190047997 - Chappie; Thomas Allen ; et al. | 2019-02-14 |
| Pyrazolopyrimidine compounds Grant 10,131,669 - Chappie , et al. November 20, 2 | 2018-11-20 |
| Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Grant 10,039,753 - Coffman , et al. August 7, 2 | 2018-08-07 |
| Pyrazolopyrimidine Compounds App 20170204099 - Chappie; Thomas Allen ; et al. | 2017-07-20 |
| 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors Grant 9,695,171 - Galatsis , et al. July 4, 2 | 2017-07-04 |
| Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors Grant 9,642,855 - Galatsis , et al. May 9, 2 | 2017-05-09 |
| Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors App 20170073343 - Galatsis; Paul ; et al. | 2017-03-16 |
| NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTITUTED-7H-PYRROLO[2,3-c]PYRIDAZINES AS LRRK2 INHIBITORS App 20170002000 - Galatsis; Paul ; et al. | 2017-01-05 |
| Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 Inhibitors App 20150366874 - Galatsis; Paul ; et al. | 2015-12-24 |
| 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Grant 9,156,845 - Galatsis , et al. October 13, 2 | 2015-10-13 |
| Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors App 20140005183 - Galatsis; Paul ; et al. | 2014-01-02 |
| Fused pyridine compounds as casein kinase inhibitors Grant 8,536,164 - Butler , et al. September 17, 2 | 2013-09-17 |
| Compounds as casein kinase inhibitors Grant 8,518,944 - Subramanyam , et al. August 27, 2 | 2013-08-27 |
| Histamine-3 receptor antagonists Grant 8,389,743 - Wager , et al. March 5, 2 | 2013-03-05 |
| Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof Grant 8,314,139 - Butler , et al. November 20, 2 | 2012-11-20 |
| Histamine-3 Receptor Antagonists App 20120220568 - Wager; Travis T. ; et al. | 2012-08-30 |
| Novel Fused Pyridine Compounds As Casein Kinase Inhibitors App 20120157440 - BUTLER; TODD W. ; et al. | 2012-06-21 |
| Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide Grant 8,178,574 - Wager , et al. May 15, 2 | 2012-05-15 |
| Histamine-3 receptor antagonists Grant 8,158,673 - Wager , et al. April 17, 2 | 2012-04-17 |
| Novel Compounds As Casein Kinase Inhibitors App 20110098272 - Subramanyam; Chakrapani ; et al. | 2011-04-28 |
| Histamine-3 receptor antagonists Grant 7,812,040 - Wager October 12, 2 | 2010-10-12 |
| Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide App 20100256213 - Wager; Travis T. ; et al. | 2010-10-07 |
| Histamine-3 Receptor Antagonists App 20090131433 - Wager; Travis T. | 2009-05-21 |
| Toluene Sulfonic Acid Salt Of A Therapeutic Compound And Pharmaceutical Compositions Thereof App 20080176925 - Butler; Todd W. ; et al. | 2008-07-24 |
| Histamine-3 Receptor Antagonists App 20080096955 - Wager; Travis T. ; et al. | 2008-04-24 |
| GSK-3 inhibitors Grant 7,300,943 - Wager November 27, 2 | 2007-11-27 |
| Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors Grant 7,300,944 - Kung , et al. November 27, 2 | 2007-11-27 |
| NK1 antagonists Grant 7,241,798 - Segelstein , et al. July 10, 2 | 2007-07-10 |
| Histamine-3 receptor modulators Grant 7,115,600 - Wager , et al. October 3, 2 | 2006-10-03 |
| Histamine-3 receptor antagonists App 20060069087 - Wager; Travis T. | 2006-03-30 |
| Histamine-3 receptor antagonist App 20060019998 - Wager; Travis T. ; et al. | 2006-01-26 |
| NK1 antagonists App 20050272800 - Segelstein, Barbara E. ; et al. | 2005-12-08 |
| Histamine-3 receptor modulators App 20050171181 - Wager, Travis T. ; et al. | 2005-08-04 |
| NK1 antagonist App 20050043354 - Wager, Travis T. ; et al. | 2005-02-24 |
| GSK-3 inhibitors App 20050026946 - Wager, Travis T. | 2005-02-03 |
| Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors App 20040266815 - Kung, Daniel W. ; et al. | 2004-12-30 |
| Pyrazole derivatives App 20020103185 - Sanner, Mark A. ; et al. | 2002-08-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 